rxstat › Shortages › Naproxen

Naproxen (Naprosyn) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Sep 25, 2026

Some Naproxen products are in shortage in Canada (6 of 29 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

An anti-inflammatory (NSAID) used to relieve pain and inflammation, such as from arthritis.

Products affected
6 / 29
In shortage since
Mar 10, 2017
Reports on file
146
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TEVA-NAPROXEN
250MG · TABLET · TEVA CANADA LIMITED
DIN 00565350 · since Jun 3, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAPROSYN
500MG · TABLET (ENTERIC-COATED) · ATNAHS PHARMA UK LIMITED
DIN 02162423 · since Jan 30, 2023, no end estimate · Demand increase for the drug.
Active shortage
NAPROSYN
750MG · TABLET (EXTENDED-RELEASE) · ATNAHS PHARMA UK LIMITED
DIN 02162466 · since Oct 2, 2024, no end estimate · Delays in manufacturing
Active shortage
NAPROSYN
500MG · TABLET (ENTERIC-COATED) · ATNAHS PHARMA UK LIMITED
DIN 02162423 · since Sep 21, 2023, no end estimate · Manufacturing delays
Active shortage
APO-NAPROXEN
375MG · TABLET · APOTEX INC
DIN 00600806 · since Mar 17, 2026, est. end Jun 12, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-NAPROXEN EC
500MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02246701 · since Feb 10, 2026, est. end Apr 24, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-NAPROXEN SR TABLETS 750MG
750MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02177072 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Resolved
APO-NAPROXEN EC TABLETS
250MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02246699 · ended Sep 22, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-NAPROXEN EC
500MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02246701 · ended Sep 24, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-NAPROXEN
375MG · TABLET · APOTEX INC
DIN 00600806 · ended Sep 10, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-NAPROXEN
500MG · TABLET · APOTEX INC
DIN 00592277 · ended Aug 20, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-NAPROXEN
250MG · TABLET · APOTEX INC
DIN 00522651 · ended Aug 20, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Naproxen is currently affected by 6 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, ATNAHS PHARMA UK LIMITED, APOTEX INC.

The reported causes are: disruption of the manufacture of the drug; demand increase for the drug; delays in manufacturing; manufacturing delays. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Naproxen is classified under “ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS” (ATC M01AE).

Recent changes

Common questions

What is Naproxen used for?

An anti-inflammatory (NSAID) used to relieve pain and inflammation, such as from arthritis.

When will Naproxen be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Naproxen in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antiinflammatory/antirheumatic prod.,non-steroids)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Misoprostol Diclofenac (Arthrotec) No current shortage Piroxicam No current shortage Sulindac No current shortage Celecoxib (Celebrex) Partial shortage 1 of 31 reported products affected Diclofenac (Voltaren Rapide) Partial shortage 1 of 8 reported products affected Ibuprofen (Novo-Profen) Partial shortage 2 of 14 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.